Seguir
Eileen Dawson
Eileen Dawson
Associate Director of Operations for the Quantum Systems Accelerator
Dirección de correo verificada de lbl.gov
Título
Citado por
Citado por
Año
Biomaterials for stem cell differentiation
E Dawson, G Mapili, K Erickson, S Taqvi, K Roy
Advanced drug delivery reviews 60 (2), 215-228, 2008
5982008
Recent advances in drug eluting stents
AS Puranik, ER Dawson, NA Peppas
International journal of pharmaceutics 441 (1-2), 665-679, 2013
1892013
Treatment of skeletal voids with implantable substrate hydrated with bone marrow concentrate
E Dawson, K Dunworth, T Sand, M Murphy, JB Rossman, M Samano, ...
US Patent 10,751,185, 2020
512020
Increased internal porosity and surface area of hydroxyapatite accelerates healing and compensates for low bone marrow mesenchymal stem cell concentrations in critically-sized …
ER Dawson, RK Suzuki, MA Samano, MB Murphy
Applied Sciences 8 (8), 1366, 2018
132018
Surface-Presentation of CpG and Protein–Antigen on Pathogen-Like Polymer Particles Generate Strong Prophylactic and Therapeutic Antitumor Protection
E Dawson, JA Leleux, P Pradhan, K Roy
ACS Biomaterials Science & Engineering 3 (2), 169-178, 2017
62017
Treatment of skeletal voids with implantable substrate hydrated with bone marrow concentrate
E Dawson, K Dunworth, T Sand, M Murphy, JB Rossman, M Samano, ...
US Patent 10,183,095, 2019
2019
Autologous Regenerative Therapies: Rapid Concentration of Progenitor Cells, Growth Factors, and Proteins at the Point-Of-Care
MB Murphy, ER Dawson, MA Samano, TT Sand
TISSUE ENGINEERING PART A 21, S235-S236, 2015
2015
Pathogen mimicking particles in an injectable synthetic-immune-priming center (sIPC) provide efficient immune cell activation and protection in murine tumor models
J Leleux, E Dawson, P Pradhan, I Sakamaki, H Qin, LW Kwak, K Roy
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–8